Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GXY
|
|||
| Former ID |
DIB020732
|
|||
| Drug Name |
piribedil
|
|||
| Synonyms |
piribedil; 3605-01-4; Trivastal; Trivastan; 2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine; ET 495; ET-495; EU-4200; EU 4200; 2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine; Piribedile [DCIT]; Piribedil [INN:DCF]; Piribedilum [INN-Latin]; UNII-DO22K1PRDJ; DO22K1PRDJ; 1-(2-Pyrimidyl)-4-piperonylpiperazine; 2-(4-Piperonyl-1-piperazinyl)pyrimidine; Pyrimidine, 2-(4-piperonyl-1-piperazinyl)-; OQDPVLVUJFGPGQ-UHFFFAOYSA-N; EINECS 222-764-6; 2-(4-(3,4-Methylenedioxybenzyl)piperazino)pyrimidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C16H18N4O2
|
|||
| Canonical SMILES |
C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4
|
|||
| InChI |
1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2
|
|||
| InChIKey |
OQDPVLVUJFGPGQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 3605-01-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3318349, 5518527, 8152983, 10589522, 11111687, 11111688, 11113867, 11467008, 11468128, 11486666, 14776022, 26752039, 29223931, 47291247, 47365330, 47515441, 47662430, 47736619, 47885534, 47885535, 48110578, 48334631, 48853191, 49699322, 50036468, 50104696, 50647529, 51091642, 57309591, 57322489, 61104879, 85209232, 85788361, 85788799, 88943151, 90341513, 92308933, 92719149, 93616730, 103113732, 104171222, 104307610, 105856731, 117603465, 124365751, 124750130, 124881234, 124881235, 124881236, 125433414
|
|||
| ChEBI ID |
CHEBI:92833
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 49). | |||
| REF 2 | Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther. 2002 Nov;303(2):791-804. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.